Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial.
作者信息
Wilson Hope P, Mosha Maua, Miller Alexandra, Betensky Marisol, Amankwah Ernest, Fargo John, Thornburg Courtney D, Tarango Cristina, Acharya Suchitra, Male Christoph, Narang Shalu, Schulman Sam, Goldenberg Neil A
机构信息
Department of Pediatrics, University of Alabama at Birmingham Heersink School of Medicine and Children's of Alabama, Birmingham, Alabama.
Department of Health Informatics, Data Coordinating Center for Pediatric Multicenter Studies, Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida.
出版信息
Semin Thromb Hemost. 2025 Apr;51(3):343-347. doi: 10.1055/s-0044-1790572. Epub 2024 Sep 19.
Abstract
摘要
相似文献
1
Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial.21岁以下患者原发性抗凝治疗后发生的诱因型静脉血栓栓塞的二级抗凝治疗：儿童DOTT试验的结果
Semin Thromb Hemost. 2025 Apr;51(3):343-347. doi: 10.1055/s-0044-1790572. Epub 2024 Sep 19.
2
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.抗凝治疗 6 周与 3 个月对 21 岁以下有诱因的静脉血栓栓塞症患者的复发和出血事件的影响：Kids-DOTT 随机临床试验。
JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182.
3
Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational Trial.21岁以下患者诱发性急性脑静脉窦血栓形成的临床特征、治疗及结局：儿童DOTT多国试验的结果
Res Pract Thromb Haemost. 2024 Oct 23;8(7):102605. doi: 10.1016/j.rpth.2024.102605. eCollection 2024 Oct.
4
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.儿童静脉血栓栓塞抗凝治疗的持续时间：儿童血栓形成治疗持续时间评估（Kids-DOTT）试验2年的结果
J Thromb Haemost. 2025 Feb;23(2):651-656. doi: 10.1016/j.jtha.2024.09.038. Epub 2024 Oct 24.
5
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.儿童和青年血栓形成治疗持续时间的多中心随机对照试验（儿童-DOTT试验）：试点/可行性阶段结果
J Thromb Haemost. 2015 Sep;13(9):1597-605. doi: 10.1111/jth.13038. Epub 2015 Aug 11.
6
Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.儿童静脉血栓栓塞症抗凝治疗的持续时间：当前方法及随机对照试验的更新情况
Expert Rev Hematol. 2018 Jan;11(1):37-44. doi: 10.1080/17474086.2018.1407241. Epub 2017 Dec 17.
7
Six Weeks Versus 3 Months of Anticoagulant Treatment for Pediatric Central Venous Catheter-related Venous Thromboembolism.小儿中心静脉导管相关静脉血栓栓塞症抗凝治疗6周与3个月的比较
J Pediatr Hematol Oncol. 2017 Oct;39(7):518-523. doi: 10.1097/MPH.0000000000000920.
8
Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial.伴有获得性静脉血栓形成和抗磷脂抗体的儿童的结局：来自 Kids-DOTT 试验的结果。
Blood Adv. 2024 Nov 26;8(22):5790-5795. doi: 10.1182/bloodadvances.2024014415.
9
Plasma fibrinolysis, inflammatory markers, and postthrombotic syndrome: preliminary findings from the Kids-DOTT Biobank.血浆纤维蛋白溶解、炎症标志物与血栓后综合征：Kids-DOTT 生物样本库的初步发现。
Blood Adv. 2021 Jan 12;5(1):233-239. doi: 10.1182/bloodadvances.2020002974.
10
Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.儿童急性静脉血栓栓塞症的延长阶段抗凝治疗：来自EINSTEIN-Jr 3期试验的队列研究
Lancet Haematol. 2025 May;12(5):e357-e364. doi: 10.1016/S2352-3026(25)00067-5. Epub 2025 Apr 10.
本文引用的文献
1
Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children's Hospital-Acquired Thrombosis Consortium.有既往静脉血栓栓塞病史的住院儿童复发性静脉血栓栓塞：儿童医院获得性血栓形成联盟的报告
Res Pract Thromb Haemost. 2023 Jun 29;7(5):102139. doi: 10.1016/j.rpth.2023.102139. eCollection 2023 Jul.
2
Impact of deep vein thrombosis on adolescent athletes: Navigating an invisible disability.深静脉血栓形成对青少年运动员的影响：应对一种无形的残疾。
Res Pract Thromb Haemost. 2022 Jul 29;6(5):e12779. doi: 10.1002/rth2.12779. eCollection 2022 Jul.
3
Secondary thrombosis prevention practice patterns in pediatrics: Results of an international survey.儿科继发性血栓形成预防的实践模式：一项国际调查的结果。
Res Pract Thromb Haemost. 2022 Apr 7;6(3):e12693. doi: 10.1002/rth2.12693. eCollection 2022 Mar.
4
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.抗凝治疗 6 周与 3 个月对 21 岁以下有诱因的静脉血栓栓塞症患者的复发和出血事件的影响：Kids-DOTT 随机临床试验。
JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182.
5
Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis.预防中心静脉导管相关性静脉血栓形成患儿的复发性血栓事件。
Blood. 2022 Jan 20;139(3):452-460. doi: 10.1182/blood.2021013453.
6
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.达比加群酯在儿童中的静脉血栓栓塞症二级预防中的安全性。
Blood. 2020 Feb 13;135(7):491-504. doi: 10.1182/blood.2019000998.
7
Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort study.高危血栓形成倾向状态对首例非中心静脉导管相关静脉血栓栓塞症儿童复发的影响：一项观察性多中心队列研究。
Br J Haematol. 2016 Oct;175(1):133-40. doi: 10.1111/bjh.14192. Epub 2016 Jun 22.
8
The impact of quality and duration of enoxaparin therapy on recurrent venous thrombosis in children.依诺肝素治疗的质量和持续时间对儿童复发性静脉血栓的影响。
Pediatr Blood Cancer. 2012 Jul 15;59(1):105-9. doi: 10.1002/pbc.23396. Epub 2011 Nov 21.
9
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies.遗传性血栓形成倾向对儿童静脉血栓栓塞的影响：观察性研究的系统评价和荟萃分析
Circulation. 2008 Sep 23;118(13):1373-82. doi: 10.1161/CIRCULATIONAHA.108.789008. Epub 2008 Sep 8.
Zotero 插件